Global commercialization

Worldwide global commercial footprint1

Over 95 countries covered through three sales channels:

Direct sales force covering Western European countries, USA and Canada
Distributor relationships in place covering ~65 countries. Distribution agreement with Nichirei Biosciences for Japanese market.

Light blue: commercialization through direct sales force
Dark blue: commercialization through distribution partners

Biocartis believes in the power of collaboration and has partnership programs with pharmaceutical and diagnostic or biomarker companies

Biocartis aims to help improve patient access to molecular diagnostics tests that drive treatment decisions.

Biocartis supports its partners to make their biomarker tests available to customers worldwide.